FDA tentatively OKs Mylan's generic drug combo for HIV

12/1/2011 | Reuters

The FDA, through the President's Emergency Plan for AIDS Relief, tentatively authorized Mylan's second-line HIV therapy comprising ritonavir and atazanavir sulfate. The ingredients are generic forms of Abbott Laboratories' Norvir and Bristol-Myers Squibb's Reyataz, respectively.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care